ICE protocol 4

chemotherapy protocol consisting of the above compounds; for treatment of chronic myelogenous leukemia; INDEXERS: has been called ICE protocol, but is not identical to our record of that name; do not confuse with miniICE

Also Known As:

AML-BFM 98; AML-BFM-87; BF12 protocol; ICE combination 4; mini-ICE protocol (ICE4)

Therapeutics: 1190486
- Drug Therapy: 300623
  - Combination Drug Therapy: 12155
    - Antineoplastic Combined Chemotherapy Protocols: 36
      - ICE protocol 4: 10
  - Antineoplastic Protocols: 58
    - Antineoplastic Combined Chemotherapy Protocols: 36
      - ICE protocol 4: 10
- Clinical Protocols
  - Antineoplastic Protocols: 58
    - Antineoplastic Combined Chemotherapy Protocols: 36
      - ICE protocol 4: 10
Heterocyclic Compounds: 207
- 1-Ring Heterocyclic Compounds
  - Pyrimidines: 521
    - Pyrimidine Nucleosides: 50
      - Cytidine: 548
        Cytarabine: 6746
        ICE protocol 4: 10
Nucleic Acids, Nucleotides, and Nucleosides: 1
- Nucleosides: 6937
  - Pyrimidine Nucleosides: 50
    - Cytidine: 548
      - Cytarabine: 6746
        ICE protocol 4: 10
  - Arabinonucleosides: 1
    - Cytarabine: 6746
      - ICE protocol 4: 10
Organic Chemicals: 140
- Hydrocarbons: 1726
  - Cyclic Hydrocarbons: 96
    - Aromatic Hydrocarbons: 295
      - Polycyclic Aromatic Hydrocarbons: 2081
        Naphthalenes: 18
        Tetrahydronaphthalenes: 1
        Podophyllotoxin: 567
        Etoposide: 10835
        ICE protocol 4: 10
        Naphthacenes
        Anthracyclines: 9615
        Daunorubicin: 2659
        Idarubicin: 932
        ICE protocol 4: 10
Polycyclic Compounds: 7
- Polycyclic Aromatic Hydrocarbons: 2081
  - Naphthalenes: 18
    - Tetrahydronaphthalenes: 1
      - Podophyllotoxin: 567
        Etoposide: 10835
        ICE protocol 4: 10
  - Naphthacenes
    - Anthracyclines: 9615
      - Daunorubicin: 2659
        Idarubicin: 932
        ICE protocol 4: 10
Carbohydrates: 22516
- Glycosides: 2186
  - Aminoglycosides: 5203
    - Anthracyclines: 9615
      - Daunorubicin: 2659
        Idarubicin: 932
        ICE protocol 4: 10
  - Glucosides: 655
    - Etoposide: 10835
      - ICE protocol 4: 10

Stephanie Ehlers Selected Research

Stephanie Ehlers Research Topics

Disease

Drug/Important Bio-Agent (IBA)

Therapy/Procedure